• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETBF2820C166E
Medical Device Problem Codes Migration or Expulsion of Device (1395); Malposition of Device (2616)
Health Effect - Clinical Code Injury (2348)
Date of Event 11/01/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant ii stent graft system was implanted in a patient for the endovascular treatment of an 65mm diameter abdominal aortic aneurysm.It was reported that a ct scan carried out approximately three years later showed a 1cm gap from the top of the graft to the lowest renal artery but there did not appear to any type ia endoleak.An intervention procedure was carried out and an 28x28x49 endurant cuff was placed to extend proximally to the level of the lowest renal artery.The cuff was ballooned and an aortogram showed no endoleak.The event was reported to be resolved.The cause of the migration is currently unknown.No additional clinical sequelae were reported and the patient is fine.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
The physician confirmed there was no migration and the gap was most likely due to the graft being placed low originally.The physician also confirmed the type ii endoleak was from the ima.It was not device or procedure related.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key8068289
Report Number2953200-2018-01574
Device Sequence Number11332544
Product Code MIH
UDI-Device Identifier00613994990969
UDI-Public00613994990969
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 02/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/08/2016
Device Model NumberETBF2820C166E
Device Catalogue NumberETBF2820C166E
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 11/06/2018
Supplement Date Received by Manufacturer11/19/2018
02/05/2019
Initial Report FDA Received Date11/14/2018
Supplement Report FDA Received Date12/10/2018
02/15/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age80 YR
-
-